Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Stocks fell on Wall Street’s first trading day of 2023 after closing out its worst year since 2008. Investors will be closely watching moves by central banks in coming months to fight inflation with higher interest rates.
